Table 1.
Basic information
| Characteristics | Group | Cases, n | PHN, n (%) | p | |
|---|---|---|---|---|---|
| Yes | No | ||||
| Gender | Male | 237 | 56 (11.15) | 181 (36.06) | 0.44 |
| Female | 265 | 69 (13.75) | 196 (39.04) | ||
| Age | ≤ 20 years | 13 | 0 (0) | 13 (2.59) | < 0.01 |
| 21–40 years | 91 | 0 (0) | 91 (18.13) | ||
| 41–60 years | 175 | 20 (3.98) | 155 (30.88) | ||
| > 60 years | 223 | 105 (20.92) | 118 (23.51) | ||
| NRS score | 3 | 7 | 0 (0) | 7 (1.39) | < 0.01 |
| 4 | 35 | 0 (0) | 35 (6.97) | ||
| 5 | 150 | 1 (0.20) | 149 (29.68) | ||
| 6 | 224 | 55 (10.96) | 169 (33.67) | ||
| 7 | 73 | 56 (11.16) | 17 (3.39) | ||
| 8 | 13 | 13 (2.59) | 0 (0) | ||
| Rash site | Head | 42 | 18 (3.59) | 24 (4.78) | < 0.01 |
| Neck and upper limbs | 96 | 43 (8.57) | 53 (10.56) | ||
| Trunk | 301 | 59 (11.75) | 242 (48.21) | ||
| Lower limbs and perineum | 63 | 5 (1.00) | 58 (11.55) | ||
| CCI score | 0 | 119 | 4 (0.80) | 115 (22.91) | < 0.01 |
| 1 | 204 | 24 (4.78) | 180 (35.86) | ||
| 2 | 95 | 30 (5.98) | 65 (12.95) | ||
| 3 | 18 | 8 (1.59) | 10 (1.99) | ||
| 4 | 26 | 22 (4.38) | 4 (0.80) | ||
| 5 | 10 | 8 (1.59) | 2 (0.40) | ||
| 6 | 11 | 11 (2.19) | 0 (0) | ||
| 7 | 9 | 8 (1.59) | 1 (0.20) | ||
| 8 | 8 | 8 (1.59) | 0 (0) | ||
| 9 | 2 | 2 (0.40) | 0 (0) | ||
| Antiviral therapy | Yes | 479 | 111 (22.11) | 368 (73.31) | < 0.01 |
| No | 23 | 13 (2.59) | 10 (1.99) | ||
| Immunosuppression | Yes | 119 | 88 (17.53) | 37 (7.37) | < 0.01 |
| No | 383 | 31 (6.18) | 346 (68.92) | ||